News reports two days ago indicated that cigarette manufacturer Philip Morris’s takeover bid for Vectura, a UK manufacturer of lung health products, looks set to go through. This is not a matter of academic integrity and I am not sure about the integrity issues pure and simple either – but there are surely ethical considerations to ponder, and ponder I do.
Last month, discussing What’s not there, I wrote about e-smoking manufacturer Juul’s purchase of the May-June edition of the American Journal of Health Behavior (AJHB); the Special Open Access Issue on JUUL comprised eleven research studies and two editorial articles on JUUL, all attempting to provide Continue reading